Table 3

HLA class I frequencies of patients with hepatitis C virus (HCV) induced end stage liver disease (n=32) versus blood donors (n=170, control group 2)

		Blood donors				HCV induced end stage liver cirrhosis		p Value
		n	%			n	%	p Value
A1	61	35.9		13	40.6	NS
A2	81	47.6		13	40.6	NS
A3	57	33.5		12	37.5	NS
A9	28	16.5		7	21.9	NS
A10	23	13.5		2	6.3	NS
A11	11	6.5		3	9.4	NS
A19	42	24.7		4	12.5	NS
A28	17	10.0		2	6.3	NS
	170			32

B5	11	6.5		5	15.6	NS
B7	52	30.6		9	28.1	NS
B8	35	20.6		13	40.6	0.027
B12	39	22.9		4	12.5	NS
B13	10	5.9		2	6.3	NS
B14	7	4.1		2	6.3	NS
B15	24	14.1		1	3.1	NS
B16	9	5.3		1	3.1	NS
B17	20	11.8		2	6.3	NS
B18	16	9.4		1	3.1	NS
B21	5	2.9		1	3.1	NS
B22	11	6.5		2	6.3	NS
B27	22	12.9		2	6.3	NS
B35	25	14.7		9	28.1	NS
B37	4	2.4		1	3.1	NS
B40	24	14.1		5	15.6	NS
B41	4	2.4		0	0.0	NS
B47	3	1.8		0	0.0	NS
B48	1	0.6		0	0.0	NS
	170			32

Cw1	13	7.6		1	3.2	NS
Cw2	25	14.7		2	6.5	NS
Cw3	47	27.7		8	25.8	NS
Cw4	27	15.9		10	32.3	NS
Cw5	26	15.3		2	6.5	NS
Cw6	34	20.0		4	12.9	NS
Cw7	91	53.5		18	58.1	NS
Cw8	6	3.5		2	6.5	NS
	170			31